Advertisement

Topics

Stealth begins SBT-20's Phase I/II trial in Netherlands to treat Huntington's disease

19:00 EDT 3 May 2017 | Net Resources International

Stealth BioTherapeutics has begun the Phase I/II CHALLENGE-HD clinical trial of SBT-20 in the Netherlands to treat patients with early stage Huntington's disease.

Original Article: Stealth begins SBT-20's Phase I/II trial in Netherlands to treat Huntington's disease

NEXT ARTICLE

More From BioPortfolio on "Stealth begins SBT-20's Phase I/II trial in Netherlands to treat Huntington's disease"

Quick Search
Advertisement
 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...